ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
19 hedge funds and large institutions have $7.74M invested in Oncternal Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
19
Holding in Top 10
–
Calls
$92K
Puts
–
Top Buyers
| 1 | +$124K | |
| 2 | +$88K | |
| 3 | +$58.4K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$13K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.47K |
Top Sellers
| 1 | -$305K | |
| 2 | -$34K | |
| 3 | -$10.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10.2K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$2K |